Skip to main content
. 2022 May 21;127(4):757–765. doi: 10.1038/s41416-022-01838-y

Fig. 3. Prognostic analysis with tumour-infiltrating lymphocytes (TILs) in intra-tumour of ICCs.

Fig. 3

a CD8+ TILs, b FoxP3+ TILs, c combination of CD8+ and FoxP3+ TILs and d FoxP3+/CD8+ TIL ratio.